Shailendra Singh shortlisted for Small Business Entrepreneur of the Year Award
Cellomatics Biosciences’ CEO and Founder, Dr Shailendra Singh, has been shortlisted for the Small Business Entrepreneur of the Year category in the 2021 Great British Entrepreneur of the Year Awards for the Midlands region. The awards, which were launched in 2012, aim to celebrate and champion entrepreneurs behind Britain’s growing businesses. Shailendra joins a shortlist of over […]
Capital Growth Fund Programme award Cellomatics Biosciences grant funding
Cellomatics has been awarded a grant from the University of Derby’s Capital Growth Fund Programme to support the purchase of new equipment. CEO and Founder, Dr Shailendra Singh comments: “This is extremely encouraging news as the grant funding further strengthens our CRO capabilities. Our vision has always been to constantly strive and add value to […]
Note from our CEO
As I reflect on the year gone by, it has been challenging for all businesses globally. My team at Cellomatics Biosciences has been extremely resilient and has fought back all the challenges posed by 2020. We have all therefore emerged unscathed and victorious. Despite the uncertainties for the most part of 2020, my team stayed […]
Cellomatics acquires new instruments to support expansion of preclinical in vitro work
Cellomatics BioSciences Ltd. remains a trusted partner in delivering pre-clinical in vitro data in areas of common medical interest including oncology, immuno-oncology, immunology, inflammation and respiratory. Our ability to provide high quality data to respected clients is a recognised asset of the company which we uphold by maintaining an updated repertoire of our in-house scientific equipment. Cellomatics […]
3D Organ-specific Models for Predicting Efficacy and Safety of the compound
Early prediction of Efficacy and Drug-induced toxicity is critical to prevent liabilities being detected at a late stage when considerable time and expense has been invested in a project. Following several well publicized drug withdrawals from the market due to toxicity and inefficacy, the industry is now keen to adopt approaches which ensure efficacy end […]